- Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
- Medifast Announces First Quarter 2024 Financial Results
- Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
- Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.83 |
---|---|
High | 24.99 |
Low | 23.78 |
Bid | 24.00 |
Offer | 24.50 |
Previous close | 25.00 |
Average volume | 389.98k |
---|---|
Shares outstanding | 10.94m |
Free float | 10.64m |
P/E (TTM) | 4.03 |
Market cap | 273.43m USD |
EPS (TTM) | 6.20 USD |
Annual div (ADY) | -- |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Sep 18 2023 |
Div pay-date | Nov 07 2023 |
Data delayed at least 15 minutes, as of May 20 2024 20:59 BST.
More ▼